Acurx Pharmaceuticals (ACXP US)

Analysis

Health Care • United States

Acurx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a new class of antibiotics for infections caused by bacteria. Acurx Pharmaceuticals serves customers worldwide.

Refresh

Company Presentation • 20 Oct 2025 19:00

Conference presentation

Company Presentation • 28 Aug 2025 19:00

Study update presentation

Company Presentation • 12 Oct 2023 19:00

Investor presentation

Company Presentation • 07 Sep 2023 19:00

World Antimicrobial Resistance Conference presentation

No more presentations

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00